Akebia Therapeutics Inc. (AX9)
Market Closed
3 Jun, 20:00
XSTU 
€
0. 8282
+0.0316
+3.97%
€
- Market Cap
- P/E Ratio
- Div Yield
16,379 Volume
- Eps
€ 0.7966
Previous Close Want to track AX9 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
AX9 Earnings Reports FAQ
What is the earnings per share (EPS) for AX9?
EPS data for AX9 is currently not available, as Akebia Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Akebia Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Akebia Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Akebia Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AX9 at this time, as Akebia Therapeutics Inc has no recent EPS data to calculate it.
